Advertisement EastMed wins clearance to market urinary incontinence product in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

EastMed wins clearance to market urinary incontinence product in US

EastMed, a medical manufacturing company that caters specifically to women's health and wellness, has received the FDA clearance to market its flagship product, uresta continence care, in the US. Uresta continence care will be available by prescription in the US.

Uresta continence care is designed to stop bladder leakage and help women to manage their stress urinary incontinence (SUI) with a conservative alternative to traditional products and surgery.

Scott Farrell, founder and vice resident of medical at EastMed, said: “SUI is a widespread, life altering condition and requires a solution that women can easily and comfortably manage. Uresta continence care restores self-confidence and allows women to improve their quality of life.”